Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)-Reference-Cited by-同舟云学术

Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)

Published:2016-06 Issue:3 Volume:12 Page:303-311
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Fokkema Marieke L.,James Stefan K.,Albertsson Per,Aasa Mikael,Åkerblom Axel,Calais Fredrik,Eriksson Peter,Jensen Jens,Schersten Fredrik,de Smet Bart J.,Sjögren Iwar,Tornvall Per,Lagerqvist Bo

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity;Current Medicinal Chemistry;2024-03

2. Aspirin-free strategy for percutaneous coronary intervention in acute coronary syndrome based on the subtypes of acute coronary syndrome and high bleeding risk: the STOPDAPT-3 trial;European Heart Journal - Cardiovascular Pharmacotherapy;2024-01-29

3. Quantitative Flow Ratio to Predict Non–Target‐Vessel Events Before Planned Staged Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome;Journal of the American Heart Association;2024-01-02

4. Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction;American Heart Journal;2023-12

5. Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial;The Lancet;2023-11